Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: Results of the CABG surgery cohort of the GUARDIAN study

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 2, 2003, Pages 420-427

  Boyce, Steven W ^a   Bartels, Claus ^b   Bolli, Roberto ^c   Chaitman, Bernard ^d   Chen, John C ^e   Chi, Eric ^f   Jessel, Andreas ^f   Kereiakes, Dean ^g   Knight, John ^h   Thulin, Lars ⁱ   Theroux, Pierre ^j  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f SANOFI   (France)

^g The Carl & Edyth Lindner Center for Research & Education   (United States)

^h Flinders Private Hospital   (Australia)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j MONTREAL HEART INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARIPORIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; PLACEBO; SODIUM PROTON EXCHANGE PROTEIN;

ADULT; AGE; AGED; ALLERGIC REACTION; ANAMNESIS; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY VESSEL MALFORMATION; COVARIANCE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FEVER; FOLLOW UP; GENDER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; NONPARAMETRIC TEST; PERIPHERAL EDEMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; URINARY TRACT INFECTION; VERTIGO; VOMITING;

EID: 0042856663     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00209-5     Document Type: Article

References (22)

1. Disch DL, O'Connor GT, Birkmeyer JD, Olmstead EM, Levy DG, Plume SK. Changes in patients undergoing coronary artery bypass graffing: 1987-1990. Ann Thorac Surg. 1994;57:416-23.
2. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 1999;34:1262-347.
3. Jones RH, Hannan EL, Hammermeister KE, Delong ER, O'Connor GT, Luepker RV, et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol. 1996;28:1478-87.
4. Theroux P. Protection of the myocardial cell during ischemia. Am J Cardiol. 1999;83:3G-9G.
5. + exchangers of mammalian cells. J Biol Chem. 1997;272:22373-6.
6. Fliegel L, Dyck JR. Molecular biology of the cardiac sodium/hydrogen exchanger. Cardiovasc Res. 1995;29:155-9.
7. Frölich O, Karmazyn M. The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res. 1997;36:138-48.
8. Fliegel L, Wang H. Regulation of the Na+/H+ exchanger in the mammalian myocardium. J Mol Cell Cardiol. 1997;29:1991-9.
9. Anderson SE, Murphy E, Steenbergen C, London RE, Cala PM. Na-H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am J Physiol. 1990;259(3 Pt 1):C940-8.
10. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:10G-8G.
11. Theroux P, Chaitman BR, Erhardt L, Jessel A, Meinertz T, Nickel WU, et al. Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial. Curr Control Trials Cardiovasc Med. 2000;1:59-67.
12. Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when n administered before or after coronary artery occlusion. J Pharmacol Exp Ther. 1998;286:175-83.
13. Linz W, Albus U, Crause P, Jung W, Weichert A, Scholkens BA, et al. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens. 1998;20:733-49.
14. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype I inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-8.
15. 2+ overload in isolated perfused rabbit heart. Circulation. 1994;89:2787-98.
16. Karmazyn M. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury: from amiloride to cariporide. Ann N Y Acad Sci. 1999;874:326-34.
17. Klein HH, Pich S, Bohle RM, Wollenweber J, Nebendahl K. Myocardial protection by Na(+)-H+ exchange inhibition in ischemic, reperfused porcine hearts. Circulation. 1995;92:912-7.
18. Theroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Circulation. 2000;102:3032-8.
19. Chaitman BR, Zhou SH, Tamesis B, Rosen A, Terry AB, Zumbehl KM, et al. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol. 1996;29:265-77.
20. Koch GG, Tangen CM, Jung JW, Amara IA. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. Stat Med. 1998;17:1863-92.
21. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol. 2001;38:1070-7.
22. Weber W, Harnisch L, Jessel A. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft (CABG) surgery. Clin Pharmacol Ther. 2002;71:457-67.